Latest News about KROS
Recent news which mentions KROS
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 12, 2024
From Benzinga
Dow Tumbles 200 Points; Liquidity Services Shares Spike Higher
December 12, 2024
From Benzinga
Gold Falls Sharply; Adobe Shares Dip After Weak Revenue Outlook
December 12, 2024
From Benzinga
Nasdaq Down 50 Points; US Initial Jobless Claims Rise
December 12, 2024
From Benzinga
Keros Therapeutics Loses 75% Value In A Single Session - Here's Why
December 12, 2024
From Benzinga
Adobe, Keros Therapeutics, Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
December 12, 2024
From Benzinga
Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst
December 03, 2024
From Benzinga
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
From Benzinga
Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
September 03, 2024
From Benzinga
KROS Stock Earnings: Keros Therapeutics Misses EPS for Q2 2024
August 07, 2024
Tickers
KROS
From InvestorPlace
From Benzinga
Tickers
KROS
From InvestorPlace
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 04, 2024
From Benzinga
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
January 04, 2024
From Benzinga
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 11, 2023
From Benzinga
Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday
December 11, 2023
From Benzinga
From Benzinga
From Benzinga
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 09, 2023
From Benzinga
Why Shares of Keros Therapeutics Jumped This Week
April 21, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
February 14, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
October 18, 2022
From Benzinga
Why Shares of Keros Therapeutics Rose 10.2% This Week
October 14, 2022
From Motley Fool
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.